10.6084/m9.figshare.8637680.v1
Ravi Potluri
Ravi
Potluri
Sandip Ranjan
Sandip
Ranjan
Hitesh Bhandari
Hitesh
Bhandari
Helen Johnson
Helen
Johnson
Andriy Moshyk
Andriy
Moshyk
Srividya Kotapati
Srividya
Kotapati
MOESM2 of Healthcare cost comparison analysis of nivolumab in combination with ipilimumab versus nivolumab monotherapy and ipilimumab monotherapy in advanced melanoma
Springer Nature
2019
Advanced melanoma
Melanoma
Nivolumab
Ipilimumab
Healthcare cost comparison
CheckMate 067
NCT01844505
2019-07-03 05:00:00
Journal contribution
https://springernature.figshare.com/articles/journal_contribution/MOESM2_of_Healthcare_cost_comparison_analysis_of_nivolumab_in_combination_with_ipilimumab_versus_nivolumab_monotherapy_and_ipilimumab_monotherapy_in_advanced_melanoma/8637680
Additional file 2. Unit cost of key resources (2017).